Literature DB >> 27807224

Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.

Xiaoquan Wang1, Natalia A Ilyushina2, Vladimir Y Lugovtsev1, Nicolai V Bovin3, Laura K Couzens1, Jin Gao1, Raymond P Donnelly2, Maryna C Eichelberger4, Hongquan Wan4.   

Abstract

Influenza A H3N2 variant [A(H3N2)v] viruses, which have caused human infections in the United States in recent years, originated from human seasonal H3N2 viruses that were introduced into North American swine in the mid-1990s, but they are antigenically distinct from both the ancestral and current circulating H3N2 strains. A reference A(H3N2)v virus, A/Minnesota/11/2010 (MN/10), and a seasonal H3N2 strain, A/Beijing/32/1992 (BJ/92), were chosen to determine the molecular basis for the antigenic difference between A(H3N2)v and the ancestral viruses. Viruses containing wild-type and mutant MN/10 or BJ/92 hemagglutinins (HAs) were constructed and probed for reactivity with ferret antisera against MN/10 and BJ/92 in hemagglutination inhibition assays. Among the amino acids that differ between the MN/10 and BJ/92 HAs, those in antigenic site A had little impact on the antigenic phenotype. Within antigenic site B, mutations at residues 156, 158, 189, and 193 of MN/10 HA to those in BJ/92 switched the MN/10 antigenic phenotype to that of BJ/92. Mutations at residues 156, 157, 158, 189, and 193 of BJ/92 HA to amino acids present in MN/10 were necessary for BJ/92 to become antigenically similar to MN/10. The HA amino acid substitutions responsible for switching the antigenic phenotype also impacted HA binding to sialyl receptors that are usually present in the human respiratory tract. Our study demonstrates that antigenic site B residues play a critical role in determining both the unique antigenic phenotype and receptor specificity of A(H3N2)v viruses, a finding that may facilitate future surveillance and risk assessment of novel influenza viruses. IMPORTANCE: Influenza A H3N2 variant [A(H3N2)v] viruses have caused hundreds of human infections in multiple states in the United States since 2009. Most cases have been children who had contact with swine in agricultural fairs. These viruses originated from human seasonal H3N2 viruses that were introduced into the U.S. swine population in the mid-1990s, but they are different from both these ancestral viruses and current circulating human seasonal H3N2 strains in terms of their antigenic characteristics as measured by hemagglutination inhibition (HI) assay. In this study, we identified amino acids in antigenic site B of the surface glycoprotein hemagglutinin (HA) that explain the antigenic difference between A(H3N2)v and the ancestral H3N2 strains. These amino acid mutations also alter binding to minor human-type glycans, suggesting that host adaptation may contribute to the selection of antigenically distinct H3N2 variants which pose a threat to public health.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  A(H3N2)v; amino acid; antigenic phenotype; hemagglutinin; influenza virus

Mesh:

Substances:

Year:  2017        PMID: 27807224      PMCID: PMC5215349          DOI: 10.1128/JVI.01512-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Age-dependent prevalence of antibodies cross-reactive to the influenza A(H3N2) variant virus in sera collected in Norway in 2011.

Authors:  K Waalen; A Kilander; S G Dudman; R Ramos-Ocao; O Hungnes
Journal:  Euro Surveill       Date:  2012-05-10

Review 2.  Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.

Authors:  Tongzhong Ju; Yingchun Wang; Rajindra P Aryal; Sylvain D Lehoux; Xiaokun Ding; Matthew R Kudelka; Christopher Cutler; Junwei Zeng; Jianmei Wang; Xiaodong Sun; Jamie Heimburg-Molinaro; David F Smith; Richard D Cummings
Journal:  Proteomics Clin Appl       Date:  2013-09-09       Impact factor: 3.494

3.  Genetic reassortment of avian, swine, and human influenza A viruses in American pigs.

Authors:  N N Zhou; D A Senne; J S Landgraf; S L Swenson; G Erickson; K Rossow; L Liu; K j Yoon; S Krauss; R G Webster
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

4.  Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011.

Authors:  Pravina Kitikoon; Amy L Vincent; Phillip C Gauger; Sarah N Schlink; Darrell O Bayles; Marie R Gramer; Daniel Darnell; Richard J Webby; Kelly M Lager; Sabrina L Swenson; Alexander Klimov
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

5.  A solid-phase enzyme-linked assay for influenza virus receptor-binding activity.

Authors:  A S Gambaryan; M N Matrosovich
Journal:  J Virol Methods       Date:  1992-09       Impact factor: 2.014

6.  Amino acid 226 in the hemagglutinin of H9N2 influenza viruses determines cell tropism and replication in human airway epithelial cells.

Authors:  Hongquan Wan; Daniel R Perez
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

7.  Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses.

Authors:  Jhang-Wei Huang; Jinn-Moon Yang
Journal:  BMC Bioinformatics       Date:  2011-02-15       Impact factor: 3.169

Review 8.  Contemporary epidemiology of North American lineage triple reassortant influenza A viruses in pigs.

Authors:  Alessio Lorusso; Amy L Vincent; Marie E Gramer; Kelly M Lager; Janice R Ciacci-Zanella
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

9.  Glycomic analysis of human respiratory tract tissues and correlation with influenza virus infection.

Authors:  Trevenan Walther; Rositsa Karamanska; Renee W Y Chan; Michael C W Chan; Nan Jia; Gillian Air; Clark Hopton; Maria P Wong; Anne Dell; J S Malik Peiris; Stuart M Haslam; John M Nicholls
Journal:  PLoS Pathog       Date:  2013-03-14       Impact factor: 6.823

10.  Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses.

Authors:  Nipaporn Tewawong; Slinporn Prachayangprecha; Preeyaporn Vichiwattana; Sumeth Korkong; Sirapa Klinfueng; Sompong Vongpunsawad; Thanunrat Thongmee; Apiradee Theamboonlers; Yong Poovorawan
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

View more
  11 in total

1.  Pathogenesis and Transmission of Genetically Diverse Swine-Origin H3N2 Variant Influenza A Viruses from Multiple Lineages Isolated in the United States, 2011-2016.

Authors:  Xiangjie Sun; Joanna A Pulit-Penaloza; Jessica A Belser; Claudia Pappas; Melissa B Pearce; Nicole Brock; Hui Zeng; Hannah M Creager; Natosha Zanders; Yunho Jang; Terrence M Tumpey; C Todd Davis; Taronna R Maines
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

Review 2.  Why Glycosylation Matters in Building a Better Flu Vaccine.

Authors:  Deborah Chang; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-10-11       Impact factor: 5.911

Review 3.  A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.

Authors:  Nicholas C Wu; Ian A Wilson
Journal:  J Mol Biol       Date:  2017-06-23       Impact factor: 5.469

4.  HA gene amino acid mutations contribute to antigenic variation and immune escape of H9N2 influenza virus.

Authors:  Rui Zhu; Shunshun Xu; Wangyangji Sun; Quan Li; Shifeng Wang; Huoying Shi; Xiufan Liu
Journal:  Vet Res       Date:  2022-06-15       Impact factor: 3.829

5.  Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.

Authors:  Hongquan Wan; Li Qi; Jin Gao; Laura K Couzens; Lianlian Jiang; Yamei Gao; Zong-Mei Sheng; Sharon Fong; Megan Hahn; Surender Khurana; Jeffery K Taubenberger; Maryna C Eichelberger
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

6.  Charged amino acid variability related to N-glyco -sylation and epitopes in A/H3N2 influenza: Hem -agglutinin and neuraminidase.

Authors:  Zhong-Zhou Huang; Liang Yu; Ping Huang; Li-Jun Liang; Qing Guo
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

7.  Antigenic cartography of H1N1 influenza viruses using sequence-based antigenic distance calculation.

Authors:  Christopher S Anderson; Patrick R McCall; Harry A Stern; Hongmei Yang; David J Topham
Journal:  BMC Bioinformatics       Date:  2018-02-12       Impact factor: 3.169

8.  Laninamivir-Interferon Lambda 1 Combination Treatment Promotes Resistance by Influenza A Virus More Rapidly than Laninamivir Alone.

Authors:  Simone E Adams; Vladimir Y Lugovtsev; Anastasia Kan; Nicolai V Bovin; Raymond P Donnelly; Natalia A Ilyushina
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

9.  The use of plant lectins to regulate H1N1 influenza A virus receptor binding activity.

Authors:  Nicolette Lee; Alexey M Khalenkov; Vladimir Y Lugovtsev; Derek D Ireland; Anastasia P Samsonova; Nicolai V Bovin; Raymond P Donnelly; Natalia A Ilyushina
Journal:  PLoS One       Date:  2018-04-09       Impact factor: 3.240

Review 10.  Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus.

Authors:  Yun Zhang; Cong Xu; Hao Zhang; George Dacai Liu; Chunyi Xue; Yongchang Cao
Journal:  Viruses       Date:  2019-04-30       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.